SCHEMBL1629037

SCHEMBL1629037

Fc1ccc(-c2nc(-c3ccccc3)c(-c3ccccc3)[nH]2)cc1

nearest known ligand 0.85

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK13 O15264 15/20 0.85
MAPK12 P53778 15/20 0.85
MAPK11 Q15759 15/20 0.85
MAPK14 Q16539 15/20 0.85
GCGR P47871 10/20 0.85
ALOX5 P09917 4/20 0.85
MAPK9 P45984 3/20 0.73
PRKD3 O94806 2/20 0.73
MAP4K4 O95819 2/20 0.73
FRK P42685 2/20 0.73
CSNK1A1 P48729 2/20 0.73
CSNK1D P48730 2/20 0.73
GSK3B P49841 2/20 0.73
PTK6 Q13882 2/20 0.73
CLK4 Q9HAZ1 2/20 0.73
PRKD2 Q9BZL6 1/20 0.73
RAF1 P04049 5/20 0.69
NOX1 Q9Y5S8 1/20 0.65
KDM4E B2RXH2 1/20 0.64
CIT O14578 1/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16292225 1.00 MAPK13 (0.85) MAPK13MAPK12MAPK11MAPK14GCGR
SCHEMBL9195042 0.92 MAPK14 (1.00) MAPK13MAPK12MAPK11MAPK14GCGR
SCHEMBL4552316 0.92 MAPK14 (1.00) MAPK13MAPK12MAPK11MAPK14GCGR
SCHEMBL19868948 0.91 MAPK14 (1.00) MAPK13MAPK12MAPK11MAPK14GCGR
SCHEMBL5074753 0.91 MAPK13 (0.83) MAPK13MAPK12MAPK11MAPK14GCGR
SCHEMBL16667652 0.89 MAPK13 (0.83) MAPK13MAPK12MAPK11MAPK14GCGR
SCHEMBL104130 0.89 MAPK13 (0.82) MAPK13MAPK12MAPK11MAPK14GCGR
Benzene SCHEMBL28852698 0.89 MAPK13 (0.82) MAPK13MAPK12MAPK11MAPK14GCGR
Methane SCHEMBL3278320 0.87 MAPK13 (0.79) MAPK13MAPK12MAPK11MAPK14GCGR
SCHEMBL3371979 0.87 MAPK14 (0.74) MAPK13MAPK12MAPK11MAPK14GCGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4321541-B1 RESIN COMPOSITION, RESIN SHEET, MULTILAYER PRINTED WIRING BOARD AND SEMICONDUCTOR DEVICE MITSUBISHI GAS CHEMICAL CO (JP) 2025-08-06 EP claimed
EP-4321541-A1 RESIN COMPOSITION, RESIN SHEET, MULTILAYER PRINTED WIRING BOARD AND SEMICONDUCTOR DEVICE MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2024-02-14 EP claimed
CN-117529509-A Resin composition, resin sheet, multilayer printed wiring board, and semiconductor device 三菱瓦斯化学株式会社 2024-02-06 CN claimed
EP-2444396-A1 PHOTOPROTECTIVE COMPOSITION Apoteknos Para La Piel, S.L. (ES) 2012-04-25 EP claimed
US-20250376527-A1 ANTAGONIST FOR TREATING MEMBRANOUS NEPHROPATHY AND USE THEREOF CHANG GUNG UNIVERSITY (TW) 2025-12-11 US disclosed
EP-4321541-B1 RESIN COMPOSITION, RESIN SHEET, MULTILAYER PRINTED WIRING BOARD AND SEMICONDUCTOR DEVICE MITSUBISHI GAS CHEMICAL CO (JP) 2025-08-06 EP disclosed
US-12221523-B2 Resin composition, resin sheet, multilayer printed wiring board, and semiconductor device MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2025-02-11 US disclosed
CN-117529509-B Resin composition, resin sheet, multilayer printed wiring board, and semiconductor device 三菱瓦斯化学株式会社 2025-01-10 CN disclosed
US-20240279432-A1 RESIN COMPOSITION, RESIN SHEET, MULTILAYER PRINTED WIRING BOARD, AND SEMICONDUCTOR DEVICE MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2024-08-22 US disclosed
EP-2247558-B2 NOVEL IMAGING AGENTS FOR DETECTING NEUROLOGICAL DYSFUNCTION LILLY CO ELI (US) 2024-07-03 EP disclosed
EP-2247558-B2 NOVEL IMAGING AGENTS FOR DETECTING NEUROLOGICAL DYSFUNCTION LILLY CO ELI (US) 2024-07-03 EP disclosed
US-11935803-B2 Resin composition, laminate, semiconductor wafer with resin composition layer, substrate for mounting semiconductor with resin composition layer and semiconductor device MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2024-03-19 US disclosed
US-8318132-B2 Imaging agents for detecting neurological dysfunction SIEMENS MEDICAL SOLUTIONS USA, INC. (US) 2012-11-27 US disclosed
EP-2444396-A1 PHOTOPROTECTIVE COMPOSITION Apoteknos Para La Piel, S.L. (ES) 2012-04-25 EP disclosed
US-20110091382-A1 NOVEL IMAGING AGENTS FOR DETECTING NEUROLOGICAL DYSFUNCTION SIEMENS MEDICAL SOLUTION USA, INC. 2011-04-21 US disclosed
US-20110091382-A1 NOVEL IMAGING AGENTS FOR DETECTING NEUROLOGICAL DYSFUNCTION SIEMENS MEDICAL SOLUTION USA, INC. 2011-04-21 US disclosed
US-20110046378-A1 Novel Imaging Agents for Detecting Neurological Dysfunction SIEMENS MEDICAL SOLUTIONS USA, INC. (US) 2011-02-24 US disclosed
EP-2247558-A1 NOVEL IMAGING AGENTS FOR DETECTING NEUROLOGICAL DYSFUNCTION Siemens Medical Solutions USA, Inc. (US) 2010-11-10 EP disclosed
WO-2009102498-A1 NOVEL IMAGING AGENTS FOR DETECTING NEUROLOGICAL DYSFUNCTION SIEMENS MEDICAL SOLUTIONS USA, INC. (US) 2009-08-20 WO disclosed
WO-2009102498-A1 NOVEL IMAGING AGENTS FOR DETECTING NEUROLOGICAL DYSFUNCTION SIEMENS MEDICAL SOLUTIONS USA, INC. (US) 2009-08-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110091382-A1 NOVEL IMAGING AGENTS FOR DETECTING NEUROLOGICAL DYSFUNCTION FABP7, TSPO, SLC18A3 MAPK13 1875/4885MAPK12 3236/4885MAPK11 2525/4885
US-20110046378-A1 Novel Imaging Agents for Detecting Neurological Dysfunction FABP7, SLC18A3, TSPO MAPK13 1982/4885MAPK12 3286/4885MAPK11 2637/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.